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CorrespondenceA Matters Arising recently pub-
lished in Cell by Kaufmann et al. 
(2007) concludes that the BH3-only 
Bid protein is dispensable for the 
DNA damage response. Based on 
our earlier findings that ATM-medi-
ated Bid phosphorylation is essen-
tial for S phase arrest and for the 
regulation of apoptosis in response 
to DNA damage (Kamer et al., 
2005; Zinkel et al., 2005), we would 
like to emphasize that we reached 
the opposite conclusion. Based 
on a careful comparison between 
the three studies (see below), we 
believe that the conclusion that Bid 
is dispensable for the DNA damage 
response is not supported by all of 
the available data.
The Kaufmann et al. experi-
ments evaluating DNA damage-
induced apoptosis differ from our 
studies in several key aspects. 
First, the mouse embryonic fibro-
blasts (MEFs) used by Kaufmann 
et al. most likely had DNA damage 
checkpoint response defects due to 
oncogene transformation (Bartkova 
et al., 2006; Di Micco et al., 2006). 
The hematopoietic cells they used 
were not homogeneous and many 
of these cells were not in cycle. 
Such cells are therefore less appro-
priate for studies of the molecular 
pathways regulated by ATM kinase 
and S phase-induced DNA damage. 
Our Kamer et al. (2005) study used 
MEFs immortalized using the cata-
lytic subunit of telomerase (hTERT). 
In contrast, Kaufmann et al. (2007) 
used MEFs transformed with the 
oncogenes E1A and Ras. Kamer et 
al. found that hTERT-immortalized 
bid−/− MEFs were much less sensi-
tive than bid+/+ MEFs to a variety of 
DNA-damaging reagents. Two other 
groups reported similar results 
using MEFs and neurons, respec-
tively (Sax et al., 2002; Jacobs et 
al., 2007). The Zinkel et al. (2005) 
study used mouse hematopoietic 
cells that were in cycle, specifically 
Hox11-immortalized early myeloid 
progenitor cells (MPCs). In contrast, 
Kaufmann et al. (2007) used HoxB8-
immortalized mouse fetal liver cells 
that displayed variable lineage and 
differentiation states (Perkins and 
Cory, 1993) as well as unfraction-
ated mouse hematopoietic cells. 
Our Zinkel et al. (2005) study found 
that bid−/− but not bid+/+ MPCs and 
primary activated T cells were 
more sensitive to replicative stress-
induced cell death. Importantly, our 
two groups found that the apoptotic 
response of bid−/− cells to DNA-dam-
aging agents was rescued by rein-
troduction of wild-type Bid, indicat-
ing that the observed differences in 
the apoptotic response between the 
bid−/− and bid+/+ cells were due to the 
absence of BID.
We have demonstrated using 
multiple cell types and a variety of 
assays that bid−/− but not bid+/+ cells 
are defective in S phase arrest fol-
lowing DNA damage. These results 
were confirmed using three inde-
pendent assays: propidium iodide 
(PI) labeling, double labeling with 
BrdU and PI, and most importantly, 
the radioresistant DNA synthesis 
(RDS) assay. The RDS assay is the 
accepted assay for interrogating the 
intra-S phase checkpoint in stud-
ies of DNA damage. Crucially, in all 
three assays, we could rescue the 
S phase arrest defect of bid−/− cells 
with wild-type Bid but not with Bid 
mutated at the ATM/ATR phosphor-
ylation sites.
Kaufmann et al. (2007) analyzed 
tumor formation in a small cohort 
of bid−/− mice of different ages. It 
is unlikely that this cohort of bid−/− 
mice, ranging in age from 14 to 21 
months (and without a wild-type 
cohort for comparison), has the sta-
tistical power to enable detection of 
the differences in tumor incidence 
observed in our Zinkel et al. (2005) 
study. The apparent lower incidence 
of leukemia seen by Kaufmann and 
Bid Plays a Role in the DNA 
Damage ResponseCell 1colleagues may reflect the younger 
ages of the mice or increased tumor 
latency due to environmental factors. 
Their pre-leukemic blood counts as 
well as their mouse that developed 
leukemia strongly suggest that the 
same phenotype is observed in 
the Zinkel and Kaufmann mouse 
colonies.
We used two methods to show that 
Bid is localized to the nucleus: (1) 
immunofluorescence using anti-Bid 
antibodies or Bid tagged with hem-
agglutinin and (2) subcellular frac-
tionation. Using subcellular fraction-
ation for nuclear proteins, we found 
that Bid was detected only in the sol-
uble/cytoplasmic fraction. However, 
pretreatment of cells with formalde-
hyde as a crosslinker prior to cellular 
disruption demonstrated that part 
of cellular Bid was localized to the 
nuclear fraction. We also demon-
strated that Bid is found in the chro-
matin fraction following replicative 
stress and released only after DNase 
treatment. These results together 
with the immunofluorescence data 
suggest that Bid is loosely associ-
ated with the nuclear fraction through 
interactions with other proteins and/
or DNA. Kaufmann et al. did not 
perform either immunofluorescence 
or crosslinker studies, and so we 
respectfully question their basis for 
concluding that Bid is localized only 
in the cytoplasmic fraction.
The most important take-home 
message in our papers is that in 
two independent well-characterized 
cell types (MEFs and MPCs), Bid is 
localized in the nucleus and phos-
phorylated by ATM (a pivotal player 
in the DNA damage response) and 
that this phosphorylation is essen-
tial for S phase arrest following DNA 
damage. These results strongly 
suggest that phosphorylation of Bid 
plays a critical role in the cellular 
response to DNA damage. A recent 
study in Nature supports a role for 
ATM-mediated Bid phosphoryla-
tion in the DNA damage response 
(Stracker et al., 2007).
How can we combine our studies, 
those of Kaufmann et al., and others 
into one coherent working model? 
Bid plays a prosurvival as well as 30, July 13, 2007 ©2007 Elsevier Inc. 
a proapoptotic function in the DNA 
damage response, and these func-
tions may be independent. We pro-
pose that in response to low levels 
of DNA damage, the ATM-depen-
dent prosurvival function springs 
into action. If this function is defec-
tive, DNA damage will accumulate 
activating a cell death pathway 
that may not involve a proapoptotic 
function of Bid. On the other hand, 
high levels of DNA damage could 
lead to activation of the proapop-
totic function of Bid in mitochon-
dria. In the case of hematopoietic 
cells, low levels of DNA damage 
may lead to “death by default” such 
that a deficiency in Bid (prosurvival 
function) results in hypersensitiv-
ity (as reported by Zinkel et al.). In 
the case of fibroblasts and neurons, 
relatively high levels of DNA dam-
age may be required to induce cell 
death, and so loss of Bid (proapop-
totic function) results in decreased 
sensitivity (as reported by Kamer, 10 Cell 130, July 13, 2007 ©2007 Elsevier
We have recently reported (Kaufmann 
et al., 2007) that, in contrast to two 
previous publications (Kamer et al., 
2005; Zinkel et al., 2005), the pro-
apoptotic BH3-only protein Bid plays 
no role in DNA damage-induced 
or replicative stress-induced cell-
cycle arrest or apoptosis. Here we 
respond to the concerns about 
our study (Kaufmann et al., 2007) 
raised by Zinkel et al. in their 
Correspondence.
A major criticism by Zinkel et al. 
is that we did not use homogeneous 
cell preparations or cells that were 
in cycle in our analyses. First, we 
would like to point out that most 
of our studies with hematopoietic 
Response: 
Does Bid Play 
DNA Damage Sax, Jacobs, and their colleagues). 
It will take more research to deter-
mine whether we are “marching” in 
the right direction.
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122, 579–591.lines are more homogeneous than 
implied by Zinkel et al., as we rou-
tinely select clones that are com-
parable with respect to rates of cell 
proliferation, morphology, and sur-
face-marker expression. Zinkel et 
al. also state that the transformed 
mouse embryonic fibroblasts we 
used are not suitable for studying 
cellular responses to DNA damage 
or replicative stress, asserting that 
oncogenic activity may obscure 
possible differences caused by loss 
of Bid. We believe that this is unlikely 
because we observed no difference 
in DNA damage-induced or replica-
tive stress-induced cell-cycle arrest 
or apoptosis between wild-type 
and Bid-deficient primary mouse 
embryonic fibroblasts (Kaufmann 
et al., 2007). Moreover, Kamer et al. 
(2005) reported that the reduction 
in UV- or γ-irradiation-induced kill-
ing of cells afforded by loss of Bid 
was even greater (~50% difference 
between wild-type and bid−/− cells; 
